Gilead Sciences Inc (GILD)

GILD (NASDAQ:Drugs) EQUITY
$80.47
pos +0.00
+0.00%
Today's Range: 80.22 - 82.25 | GILD Avg Daily Volume: 9,644,400
Last Update: 06/24/16 - 4:00 PM EDT
Volume: 0
YTD Performance: -20.49%
Open: $0.00
Previous Close: $83.37
52 Week Range: $81.28 - $123.37
Oustanding Shares: 1,331,821,506
Market Cap: 111,033,958,955
6-Month Chart
TheStreet Ratings Grade for GILD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 9 9 9
Moderate Buy 2 2 2 2
Hold 7 7 6 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.94 1.89 1.82 1.75
Latest Dividend: 0.47
Latest Dividend Yield: 2.26%
Dividend Ex-Date: 06/14/16
Price Earnings Ratio: 6.95
Price Earnings Comparisons:
GILD Sector Avg. S&P 500
6.95 7.00 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-11.89% -34.05% 64.44%
GROWTH 12 Mo 3 Yr CAGR
Revenue 31.10 2.40 0.49
Net Income 50.10 6.00 0.90
EPS 62.00 6.20 0.92
Earnings for GILD:
EBITDA 23.29B
Revenue 32.64B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $2.96 $2.95 $11.81 $12.51
Number of Analysts 2 2 2 2
High Estimate $3.09 $3.14 $12.39 $13.78
Low Estimate $2.83 $2.76 $11.23 $11.23
Prior Year $3.10 $3.19 $12.45 $11.81
Growth Rate (Year over Year) -4.52% -7.52% -5.14% 5.88%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
A new low down at $80 might be just enough weakness to prompt further declines.
Large biotech stocks are still at their cheapest valuations since 2011.
This is the group that is the most dangerous politically.

Takeaways and Observations Real Money Pro($)

It was Groundhog Day on Wall Street again. We finished down, but well off of the session lows. I did no trading. The U.S. dollar weakened. Oil, stronger in the morning, weakened in

My Latest Trades Real Money Pro($)

I sold my SPY June $208 puts at breakeven a few minutes ago. There are only two weeks left until this put expires, so I'm moving on. I've liquidated the balance of my four-stock
This well-managed biotech company is trading for its lowest price/earnings multiple ever.

My Morning Musings Real Money Pro($)

The Materials Select Sector SPDR ETF (XLB) -- this week's Short Trade of the Week -- initially fell, but ended higher on the day. I plan to add to this short today on any further strength. The Consumer Staples Select Sector SPDR ETF (XLP), last week's Short Trade of the Week, also rose. Defensive staples were strong throughout the afternoon. I've moved my short book's emphasis over the past several weeks to individual securities and sectors and away from broad bets like shorts of the SPDR S&P 500 ETF (SPY) and the PowerShares QQQ ETF (QQQ). That's because the former is working better than the l

My Takeaways and Observations Real Money Pro($)

The U.S. dollar advanced modestly. I continue to see more strength ahead, which should help my Consumer Staples Select Sector SPDR ETF (XLP) short (last week's Trade of the Week) and my XLB short (this week's Trade of the Week). Crude oil declined by 42 cents and is under $49. I am short energy stocks and I wouldn't be surprised if oil prices rolled over in the face of (1) the recent rip and (2) more evidence of slowing domestic economic growth. Nat gas rose by 12 cents. Gold rose by $2.80 and is trading at $1,219; my guess is $1,150 before $1,300, but this is a non-rigorous guess! Agricultural commodities got schmeissed: wheat -15.50, corn -7.75 (UBS raised Deere (DE) based on higher corn prices -- we will see!), soybeans -8.0 and oats -3.75. Lumber -6.40. Bonds were better bid. The yield on the 10-year note was down a basis point at 1.83% and the long bond also was basis point lower at 2.635%. Municipals were slightly higher in price and lower in yield. Closed-end municipal bond funds were mixed. High yield was sold. Blackstone/GSO Strategic Credit Fund (BGB) was flat after making a near-term high earlier in the morning at $14.40. Banks reversed to the downside after morning gains. I would continue to avoid them, but I am in the minority. Seems like every talking head now loves the space after rejecting banks at the lows. Insurance got hit, though my long Hartford Financial Services Group (HIG) outperformed Lincoln National (LNC) and MetLife (MET) --- a good thing. Brokerages also reversed good gains in the a.m. I'm not interested here with capital markets dull and trading light. iShares Nasdaq Biotechnology ETF (IBB) was up $3 but off the day's highs. AGN now is reversing back into the red. Valeant (VRX) can't rally. Gilead Sciences (GILD), Celgene (CELG) and Intrexon (XON) -- three other recent additions -- are trading well. Energy stocks were conspicuously weak despite a quiet day in the commodity. Media, led by Disney (DIS), was weaker. I addressed DIS earlier in the day. Staying short. Autos turned lower, but fractionally so. I still endorse the Peak Autos thesis. Agricultural equipment was trading better on the Deere upgrade, but sense it will be short-lived. Retail was mixed, but my shorts Nordstrom (JWN) and Foot Locker (FL) were lower by about half a beaner. I have no longs and don't anticipate a move in the retail space on the long side. Staples were broadly lower, a good thing for last week's Trade of the Week, short XLP. TFANG was buoyed by another new high in Amazon (AMZN), up $8.50. Others were fading. NOSH -- all four names were lower, led by Home Depot (HD), O'Reilly Automotive (ORLY) and Nike (NKE). In individual names, Potash (POT) suffered a downgrade by Stifel.  The MIghty Oak, Oaktree Capital Group (OAK), was up on the day. Twitter (TWTR) continues to rally, albeit from low levels. Apple was down $1.10 on the upgrade cycle lengthening news (see above). Mortgage insurance was flat.  Here are five good columns from Real Money Pro today: Jim "El Capitan" Cramer sees bargains. I see few sectors or stocks that meet my standards of value. Ben "Goldfinger" Cross sees the credibility of the Fed put to the test. This is a refrain of mine for the last 12 months.  Tom Graff asks what numbers are most meaningful to the Fed. Tim "Not Judy or Phil" Collins on alphabet soup!  Divine defines sentiment  and RevShark goes Tina Turner on us.
Bonds are near the day's high, with iShares 20+ Year Treasury Bond ETF (TLT) up 75 cents, and bank stocks are near the day's lows. Limited volatility along most industry sectors today. Allergan (AGN) and Celgene (CELG) -- half of my latest biotech basket -- were up $4.80 and $1, respectively. Gilead Sciences (GILD) was down $1. No follow through from homebuilding stocks. I cautioned yesterday about housing and Mark Hanson cautions today in the previous post. As of 3 p.m. it appears to be the smallest range in the S&P Index that I can remember on an intraday basis. More changes at Twitter (TWTR) -- this time, the heads of business development and media. To me this is an indication that progress has been slow and that the heavy lifting and execution of strategy will take more time than most expected. An active IPO day for a change. Six in total. Robert "Not Rita" Moreno disses Disney (DIS) shares on a technical basis today.  My concerns  are fundamental and are based on the belief that the company's secular earnings-per-share growth rate is under 10% annually compared to historic 18% to 19% annual growth and consensus of 12% to 14% per year. Sometimes things are so quiet it is hard not to fall asleep. But, given my

Columnist Conversations

.... that Monday is a total bloodbath.
I was going to publish a thought piece on Pandora and Groupon for the weekend; but it will get lost with all o...
Clorox is trading at new all time highs today with the help of a nice bump in trade.  The stock is up just ov...
Spot Gold has hurdled-- and is sustaining above-- its prior significant rally peak at $1307.40, which has the ...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.